Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

  • The Lancet, August 2001, Elsevier
  • DOI: 10.1016/s0140-6736(01)05775-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s0140-6736(01)05775-0

The following have contributed to this page: Professor Luigi P. Badano